Page last updated: 2024-08-25
epiroprim and Sepsis
epiroprim has been researched along with Sepsis in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Angehrn, P; Hartman, PG; Locher, HH; Schlunegger, H; Then, RL | 1 |
Other Studies
1 other study(ies) available for epiroprim and Sepsis
| Article | Year |
|---|---|
Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone.
Topics: Animals; Dapsone; Drug Combinations; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Sepsis; Trimethoprim | 1996 |